In addition to 100% of Purdue’ assets being included in the bankruptcy, the Sackler family, which is the majority owner of the privately-held company, agreed to contribute a minimum of $3 billion, with the potential for substantial further monetary contributions from the sales of their ex-U.S. pharmaceutical businesses, such as Mundipharma, which has been pegged at a value of about $1.5 billion throughout the settlement discussions.